News | Artificial Intelligence | April 18, 2019

FocalNet artificial neural network achieves 80.5 percent accuracy in reading MRI scans for prostate cancer, compared to 83.9 percent for experienced radiologists

Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer

April 18, 2019 — University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to help radiologists improve their ability to diagnose prostate cancer. The system, called FocalNet, helps identify and predict the aggressiveness of the disease by evaluating magnetic resonance imaging (MRI) scans, and it does so with nearly the same level of accuracy as experienced radiologists. In tests, FocalNet was 80.5 percent accurate in reading MRIs, while radiologists with at least 10 years of experience were 83.9 percent accurate.

Radiologists use MRI to detect and assess the aggressiveness of malignant prostate tumors. However, it typically takes practicing on thousands of scans to learn how to accurately determine whether a tumor is cancerous or benign, and to accurately estimate the grade of the cancer. In addition, many hospitals do not have the resources to implement the highly specialized training required for detecting cancer from MRIs.

FocalNet is an artificial neural network that uses an algorithm that comprises more than a million trainable variables; it was developed by the UCLA researchers. The team trained the system by having it analyze MRI scans of 417 men with prostate cancer; scans were fed into the system so that it could learn to assess and classify tumors in a consistent way and have it compare the results to the actual pathology specimen. Researchers compared the artificial intelligence system’s results with readings by UCLA radiologists who had more than 10 years of experience.

The research suggests that an artificial intelligence system could save time and potentially provide diagnostic guidance to less-experienced radiologists.

The study’s senior authors are Kyung Sung, assistant professor of radiology at the David Geffen School of Medicine at UCLA; Steven Raman, M.D., a UCLA clinical professor of radiology and a member of the UCLA Jonsson Comprehensive Cancer Center; and Dieter Enzmann, M.D., chair of radiology at UCLA. The lead author is Ruiming Cao, a UCLA graduate student. Other authors are Amirhossein Bajgiran, Sohrab Mirak, Sepideh Shakeri and Xinran Zhong, all from UCLA.

The research is published in IEEE Transactions on Medical Imaging,1 and was presented at the IEEE International Symposium on Biomedical Imaging (ISBI), April 8-11 in Venice, Italy, where it was selected as the runner up-for best paper.

For more information: www.ieeexplore.ieee.org

 

Reference

1. Cao R., Bajgiran A.M., Mirak S.A., et al. Joint Prostate Cancer Detection and Gleason Score Prediction in mp-MRI via FocalNet. IEEE Transactions on Medical Imaging, published online Feb. 27, 2019. DOI: 10.1109/TMI.2019.2901928

Related Content

News | Magnetic Resonance Imaging (MRI)

December 1, 2021 — In the first MRI-based study to investigate prenatal alcohol exposure, researchers found significant ...

Time December 01, 2021
arrow
News | Coronavirus (COVID-19)

November 30, 2021 — COVID-19 of mild to moderate severity in pregnant women appears to have no effect on the brain of ...

Time November 30, 2021
arrow
News | Coronavirus (COVID-19)

November 29, 2021 — The largest multi-institutional international study to date on brain complications of COVID-19 has ...

Time November 29, 2021
arrow
News | Coronavirus (COVID-19)

November 29, 2021 — A small but significant percentage of college athletes with COVID-19 develop myocarditis, a ...

Time November 29, 2021
arrow
News | Artificial Intelligence

November 28, 2021 — Lunit, a medical AI provider, is returning to the 107th Radiological Society of North America (RSNA) ...

Time November 28, 2021
arrow
News | Artificial Intelligence

November 28, 2021 — Rhino Health announced a pilot project with the pancreatic cancer working group of the Early ...

Time November 28, 2021
arrow
News | Enterprise Imaging

November 28, 2021 — Aidoc, a provider of artificial intelligence (AI) solutions for medical imaging, announced the ...

Time November 28, 2021
arrow
News | Breast Imaging

Lunit, a leading medical AI provider, announced that the U.S. Food and Drug Administration (FDA) 510(k) has cleared its ...

Time November 28, 2021
arrow
News | Artificial Intelligence

November 28, 2021 — Motilent, the first company to specialize in the assessment of digestive diseases using AI medical ...

Time November 28, 2021
arrow
News | Artificial Intelligence

November 28, 2021 — Riverain Technologies, a leader in artificial intelligence (AI) for early, efficient detection of ...

Time November 28, 2021
arrow
Subscribe Now